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Visualizing the RAGE
Molecular Imaging After MI Provides Insight Into a Complex Receptor*
Francis G. Spinale, MD, PHD
Columbia, South Carolinat
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wChanges in left ventricular (LV) myocardial struc-
ture (remodeling) often occurs after a myocardial
infarction (MI) and contributes to the progression
to heart failure. Although it is clear there is no
single pathway or event that contributes to adverse
LV remodeling after MI, the inflammatory cascade
that entails the release of biologically active mole-
cules (cytokines) likely plays a central role in this
process. Specifically, while inflammation is critical
for the appropriate wound healing response, the
See page 59
biological mediators attendant to the inflammatory
response also likely contribute to adverse remodel-
ing through a number of intracellular and extracel-
lular proteolytic pathways. Thus, the early post-MI
period can yield a feed-forward process of cellular
and extracellular events that initiate and promulgate
the adverse remodeling process. Peripheral blood
sampling can provide invaluable information on the
initial degree of myocardial injury and the magni-
tude of the inflammatory response. However, these
surrogate chemical measurements do not provide
spatial specificity, and therefore do not provide
critical information on the anatomic location of
the region or regions undergoing or at risk for
undergoing adverse LV remodeling. In this issue of
iJACC, Tekabe et al. (1) have addressed this re-
search goal through a feasibility study whereby a
specific receptor, the receptor for advanced glyca-
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arly in the post-MI inflammatory-signaling cas-
ade was imaged in a murine MI model.
AGE signaling and relevance to MI. Requisite events
n the LV remodeling process include changes in
rotein stability and turnover, which in turn will
lter cellular and extracellular structure-function
elationships. A clear example of changes in protein
tability and turnover is that of post-translational
odification, which occurs with the formation of
dvanced glycation end products (AGEs). One
onsequence of changes in protein turnover and
ross-linking occurring with AGEs is fibrillar col-
agen, whereby increased collagen accumulation can
ccur, causing myocardial fibrosis and abnormalities
n LV diastolic function (2). Although post-
ranslational modification of proteins was initially
onsidered to be the primary consequence of AGE
ormation, AGEs serve as ligands for a transmem-
rane receptor, namely, RAGE. As RAGE is a
ember of the superfamily of immunoglobulin
eceptors, it therefore is not surprising that there are
ultiple ligands for RAGE. In particular, it has
een documented that specific components of the
nflammatory cascade, such as S100B, serve as
igands for RAGE (3). This may be of particular
elevance with respect to ischemia-reperfusion as
100B can be released as a consequence of necrotic
ell death, apoptosis, and autophagy—all likely
ccurring in this pathological context. Thus,
AGE can be activated after MI without the
bsolute presence of AGEs. Intracellular transduc-
ion of RAGE appears to be through the classical
itogen-activated protein kinases and extracellular
ignal-regulated kinases, resulting in the formation
f transcription factors such as nuclear factor kappa
. This receptor transduction pathway for RAGE
ould, therefore, likely cause the elaboration of
roinflammatory cytokines. Thus, the up-regulation
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69of RAGE would in turn cause a number of biolog-
ical cascades that would contribute to the adverse
LV remodeling process with MI. Indeed, in trans-
genic mice with gene deletion for RAGE, the initial
LV remodeling and dysfunction that invariably
occurs in the murine MI model was ameliorated (4).
Furthermore, the use of a ligand decoy and a soluble
RAGE ligand could also attenuate early post-MI
remodeling in this mouse model (4). The study by
Tekabe et al. (1) represents a fundamental leap
forward with respect to RAGE biology and
post-MI remodeling by developing a method to
visualize RAGE expression within the intact mu-
rine system through the use of a radiolabeled
RAGE antibody. Through this approach, these
investigators provide the first demonstration in vivo
that an up-regulation of RAGE occurs early
post-MI and is localized to the region of the left
ventricle at most risk for adverse remodeling.
Visualizing RAGE and MI. In the study by Tekabe et
al. (1), dual isotope imaging using single-photon
emission computed tomography/computed tomog-
raphy (SPECT/CT) was performed in a rat model
of ischemia-reperfusion and subsequent MI. For
the purposes of visualizing RAGE, a fragmented
antibody targeted against the extracellular
V-domain was conjugated with 99mTc (99mTc-
antiRAGE) and injected at 20 h or 48 h post-MI
induction. At 5 h after this initial injection,
thallium-201 was injected and dual SPECT/CT
performed. The investigators reported more than a
fourfold increase in 99mTc-antiRAGE uptake
ithin the MI region at 20 h post-MI, which,
hile remaining detectable, was significantly di-
inished by 48 h post-MI. Ex vivo well counting
onfirmed these in vivo imaging results, and immu-
ohistochemistry demonstrated localization to the
ite of ongoing myocardial injury and remodeling.
he investigators reported that the RAGE local-
zation was particularly prevalent where myocyte
poptosis may be occurring within the MI region.
This study is significant from both a basic and a
ranslational research perspective. From the basic
cience perspective, this study clearly demonstrated
hat an induction of RAGE occurs after myocardial
njury and that the presence of AGEs is not a
equisite for this receptor up-regulation. The local-
zation of RAGE to the site of myocardial injury is
onsistent with the induction of the inflammatory
ascade that occurs early post-MI, but more impor-
antly, may have been co-localized to cardiac myo-
ytes undergoing apoptosis. These observations
ould, therefore, support the postulate that theelease of intracellular S100B by cells undergoing
poptosis would provide a ligand for the RAGE
eceptor. From a translational research perspective,
hese studies demonstrate the feasibility of quanti-
ying biological events in an intact physiological
ystem that holds relevance to post-MI remodeling.
Other studies have similarly identified the feasi-
ility of imaging matrix metalloproteinase activity
nd angiogenesis in rodent models of MI (5–7). As
ith any feasibility study of this type, the study by
ekabe et al. (1) identifies a number of issues that
ill warrant investigation in the future. First, what
re the critical cell types that express RAGE in the
ost-MI period that, in turn, directly contribute to
he post-MI remodeling process? The current study
olocalized RAGE to cardiomyocytes presumably
ndergoing apoptosis, but a major cell type that
xpresses RAGE is the macrophage. In fact, the
ame investigators reported in another murine
odel of cardiovascular disease that the 99mTc-
antiRAGE signal was primarily localized to the
macrophage (6). The macrophage, through direct
and indirect effects, plays a significant role in the
post-MI remodeling process; thus, whether up-
regulation of RAGE in these cells is a relevant
signaling pathway remains to be established. A
limitation of the present study was the slow clear-
ance of 99mTc-antiRAGE from the blood pool,
which restricted the temporal resolution by which
these studies could be performed, and further re-
quired a significant delay for the parallel perfusion
imaging studies. Nevertheless, this study provides
convincing imaging that an early up-regulation of
RAGE occurs in a small animal model of MI.
Future studies that induce hyperglycemia and the
formation of AGEs in this rodent MI model would
be a provocative direction to take with these RAGE
imaging studies.
The study by Tekabe et al. (1) continues to
provide a solid foundation and proof of concept that
in vivo imaging of biological signaling cascades and
pathways that are induced after MI is feasible.
These basic imaging studies set the foundation by
which to determine the relationship between in vivo
quantification of biological signaling events to the
progression and magnitude of adverse LV remod-
eling. The ability to perform molecular imaging
coupled with measurements of LV geometry and
function most certainly hold relevance to develop-
ing predictive models for prognosis and eventual
treatment efficacy in the post-MI period. Of course,
extrapolating a rodent study to clinical applications
must be done with great caution, and up-titration of
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70these studies to more clinically relevant large-
animal model imaging will be essential. However,
our laboratory has demonstrated that translation of
murine imaging to clinically relevant post-MI mod-
els can be successfully performed (7). Thus, it would
seem likely that clinical feasibility studies that
perform imaging of cellular and molecular events,TG. S100B interaction with the recep-
tor for advanced glycation end products
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Development of rece
glycation end produthis issue of iJACC (1), as well as by others (5–7),
re in the not too distant future.
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